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INTRODUCTION 
Cytochalasin B, a mold metabolite, has been shown 
to  inhibit  cytokinesis  and  motility  (3),  morpho- 
genie development  (18),  endocytosis  (5),  and  the 
transport  of sugars  (8-10,  12).  It  has  also  been 
demonstrated  that  this  drug  inhibits  the  stimu- 
atcd  elaboration  of extracellular substances  from 
glands--the  release of thyroxine from the thyroid 
gland  after  stimulation  by  thyroid-stimulating 
hormone (TSH) (19), and the release of o~-amylase 
from  the  parotid  gland  after  stimulation  by  epi- 
nephrine  (1). 
To date,  the  effects of cytochalasin  B  on  other 
aspects  of hormone-mediated  responses  have  not 
been reported.  Therefore, studies were initiated to 
study the effects of the drug on another hormone- 
modified system--the induction of tyrosine amino- 
transferase  (E.C.  2.6.1.5)  by  insulin,  cortisol,  or 
N6-2CO-dibutyryl  adenosine-31-5r-cyclic  mono- 
phosphate.  These  studies  were  carried  out  with 
Reuber hepatoma  (H-35)  cells grown in culture. 
MATERIALS  AND  METHODS 
Reubcr  hepatoma  (H-4-II-E,  also  referred  to  as 
H-35)  cells  were  cultured  in  Swim's  77  modified 
medium  as  a  nonconfluent  monolayer  according  to 
the  previously  published  procedure  (2).  The  H-35 
cells were used in these experiments when they were 
in  a  mid-log phase  of growth.  The cells were incu- 
bated with insulin (0.5  #g/ml), cortisol (50 #M final 
concentration),  or  dibutyryl  cyclic  AMP  (0.5  mM 
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0.16  M NaC1 for 6 or 4 h before their harvest and the 
preparation of cell extracts (2). 
In all experiments, the H-35 cells were incubated 
with dimethyl sulfoxide (DMSO)  or cytochalasin B, 
dissolved in a  corresponding amount of DMSO,  for 
30  rain  at  37°C  in  Swim's  77  medium before the 
addition of the hormones or cyclic nucleotide. 
Tyrosine aminotransferase (TAT)  was assayed by 
the procedure of Diamondstone (6).  1 U  of TAT is 
equivalent to the formation of 1 #mole ofp-hydroxy- 
phenylpyruvate per hour by 1 mg of extract protein. 
Protein was determined by the procedure of Lowry 
etal.  (11). 
Cytochalasin B was a gift from Dr.  S. B. Carter of 
the Imperial Chemical Co.  (Los Angeles, Calif.) and 
was  made  up  to  5  mg/ml  in  dimethyl  sulfoxide 
(DMSO). Insulin was donated by Dr. W. R. Kirtley 
of the Eli Lilly & Co., Indianapolis, Ind. Cortisol was 
from  the  Upjohn  Co.,  Kalamazoo,  Mich.  NS-2  '- 
0-dibutyryl  adenosine-3'-J-eyclie  monophosphate 
was  purchased  from  Schwarz/Mann,  Orangeburg, 
N. Y. The [14C]cortisol and [3H]dibutyryl cyclic AMP 
were purchased from the New England Nuclear Corp. 
(Boston,  Mass.).  [12H]insulin  was  obtained 
Amersham/Searle Corp., Arlington Heights, Ill. 
RESULTS  AND  DISCUSSION 
Induction  of  Tyrosine  Aminotransferase 
Cytochalasin B  (50  ]zg/ml of culture  medium) 
completely  inhibited  the  induction  of  TAT  by 
either insulin or cortisol  (Table  I).  At  a  concen- 
tration of l0  ~g/ml,  the  drug  inhibited the hor- 
mone-induced  effect  to  a  small  but  significant 
extent.  At  a  concentration  of  1.0  jzg/ml,  cyto- 
chalasin  B  was  without  effect  on  the  hormone- 
inducible levels of TAT. 
Dibutyryl cyclic AMP, at a concentration of 500 
]~M,  induced  the  formation  of TAT  (Table  I). 
However, unlike  its inhibition of the insulin  and 
cortisol induction of TAT,  cytochalasin B  had no 
effect on the cyclic AMP inducing system. 
The synthesis of new enzyme is  implicit in  the 
hormone  and  cyclic  AMP  induction  of tyrosine 
aminotransferase. However, since we have found a 
TABLE  I 
The Effect of Cytochalasin  B  on the Induction  o/ Tyrosine Aminotransferase  by Insulin,  Cortisol,  or Dibutyryl 
Cyclic AMP in Reuber H-35 Hepatoma  Cells 
Units of tyrosine aminotransferase 
Additions  Untreated  Insulin  Corlisol  DBC AMP 
Experiment 1 
None  1.29  4-  0.1  3.31  4-  0.07 
DMSO  (1.0%)  1.35  -4-  0.07  3.45  4-  0.11 
Cytochalasin B  (50  1.23  4-  0.07  1~55  4-  0.09 
#g/ml) 
Experiment 2 
DMSO  (0.5%)  1.51  4-  0.01  3,15  4-  0.25 
Cytochalasin B  (1  1.40  -4-  0.12  3,00  4-  0.30 
/.tg/ml) 
Cytochalasin B  (10  1.35  4-  0.06  2.20  4-  0.01 
/~g/ml) 
Experiment 3 
DMSO  (0.4%)  1.40  4-  0.03  3.03  4-  0.02 
Cytochalasin B  (10  1.31  4-  0.03  2.33  4-  0,06 
#g/ml) 
Cytochalasin B  (20  1.30  4-  0.02  2.02  -4-  0,02 
#g/ml) 
4.85  4-  0.10 
4.70  -4-  0.30 
1.42  4-  0.15 
3.25  4-  0.05 
3.30  4-  0.10 
2.60  4-  0.10 
2.40  4-  0.01 
2.36  4-  0.06 
2.72  4-  0.04 
H-35 hepatoma cells were incubated for 30 rain at 37°C in Swim's 77 medium containing DMSO, 0.4-1.0% 
(vol/vol), and varying concentrations of cytochalasin B dissolved in a corresponding amount of DMSO. 
At  the end of the preincubation period, insulin at 0.5  /zg/ml, cortisol to a  concentration of 50  /~M, or 
dibutyryl cyclic AMP (DBC-AMP) to a concentration of 0.5 nlM was added, and the hepatoma cells were 
incubated for 6 h  (experiment 1)  or 4  h  (experiments 2 and 3). After incubation, the plates were rinsed 
with Swim's 77 medium, and a cell extract was prepared. The results are the mean 4- SE of three to four 
plates per point. 
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The Effect of Cytochalasin B  on the Binding  and Uptake o] Insulin,  Cortisol, and Dibutyryl  Cyclic AMP by 
Reuber H-35 Hepatoma Cells 
Additions 
Quantity of hound hormone or dibutyryl cyclic AMP 
Insulin (ng/mg protein)  Cortisol  (nmoles/plate)  DBC-AMP (nmoles/plate) 
Experiment 1 
None 
DMSO  (0.2%) 
Cytochalasin B  (1  /~g/ml) 
Cytoehalasin B  (t0 Ng/ml) 
Experiment 2 
DMSO  (0.5%) 
Cytochalasin B  (20 #g/ml) 
1.48  4-  0.13 
1.30  4-  0.10 
1.44  4-  0.19 
1.30  4-  0.05 
1.2  -4-  0.1  4.4  -4-  0.1 
1.3  -4-  0.1  4.4  -4-  0.1 
H-35 cells were incubated  for 30  min at 37°C in 2 ml of Swim's 77 medium containing cytochalasin B, 
1-20 btg/ml, and  a corresponding quantity of DMSO. The pretreated  plates were incubated with radio- 
labeled hormone or dibutyryl cyclic AMP (DBC-AMP) for designated periods of time:  [l~-~Ilinsulin  (1 /.tg, 
sp act 36 nCi/#g) for 3.5 h, a time at which the cell-associated radioactivity was at equilibrium; [l*C]cor- 
tisol (final concentration, 50/.tM and 25 nCi) for 1 h, a time at which the cell-associated radioactivity was 
at equilibrium; and  [3H]dibutyryl  cyclic AMP  (final concentration,  0.5 mM and 0,75 #Ci)  for 1 h. The 
uptake of cyclic AMP was linear out to 3 h. After incubation,  the plates were washed in several volumes 
of 0.154 M  NaC1, the cells digested in 0.2 N  NaOH,  and portions taken for the determination of protein 
and for the determination of radioactivity. The results are expressed as the mean 4- SE of four plates. 
differential  inhibition  by  cytochalasin  B  on  the 
induction  of this  enzyme,  it would  seem unlikely 
that the failure to induce the formation of enzyme 
is the result of an inhibition of protein synthesis. In 
support of this conclusion, it was found that incu- 
bation of H-35 cells for 3.5 h  with cytochalasin B 
at  a  concentration  (20  gg/ml,  experiment  3  in 
Table  I)  that produced  a  significant inhibition of 
enzyme induction did not inhibit the incorporation 
of a  30 min pulse of radiolabeled leucine (data not 
presented).  This observation is in agreement with 
those of others (7,  15) using different cell lines, but 
does  not  agree  with  the  data  of  Springer  and 
Perdu0,  who found a  20 %  decrease in amino acid 
incorporation  during  a  1  h  incubation  with  the 
drug in cultured chick embryo fibroblasts. Another 
possible  explanation  for the effect of cytochalasin 
B  on  hormone  versus  cyclic  AMP  induction  of 
tyrosine aminotransferase  could be through  a  dif- 
ferential  uptake  or  binding  of insulin  or  cortisol 
compared with that of the nucleotide. 
Binding  and  Uptake of Insulin,  Cortisol,  and 
Cyclic AMP 
Cytochalasin B, at concentrations of 1-20 #g/ml, 
di:l not inhibit the binding and subsequent uptake 
I Springer,  A.,  and  J.  F.  Perdue.  Manuscript  sub- 
mitted for publication. 
of insulin, cortisol, or cyclic AMP (Table II). The 
cells incubated  in dimethyl sulfoxide had  levels of 
hormone  binding which were comparable  to that 
observed for untreated cells (Table II). No attempt 
was made  to determine whether  the radioactivity 
taken  up  was  still  in  the  form  of  the  parent 
compound. 
The  active  transport  of  sugars  across  the  cell 
membrane  represents  one  plasma  membrane- 
associated  system  which  is  very  sensitive  to  en- 
vironmental conditions,  such as pH,  serum levels, 
and  the  degree  of  cell  confluency  (4,  14).  This 
system is also sensitive to cytochalasin B.  Kletzien 
et al. (9)  and Kletzien and Perdue (10) found that 
at  a  concentration  of  70  ng/ml,  50  percent  of 
2-deoxy-D-glucose  uptake  was  inhibited.  At  this 
concentration  of  metabolite,  there  were  no  de- 
tectable changes in cell shape. 
It may be inferred  from this work  (9,  10)  that 
minor perturbations  of the membrane-cell cortex 
regions  brought  about  by local depolymerization 
of microfilaments or microtubules could influence 
plasma membrane functions. In this regard, Ukena 
and  Berlin  (16)  have  found  that  treating  poly- 
morphonuclear  leukocytes  with  colchicine  or 
vinblastine,  drugs  which  depolymerize  microtu- 
bules,  disrupted  the  geographically  separated 
plasma  membrane  functions  of phagocytosis  and 
adenine  and  lysine  transport.  However,  the  hy- 
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elements of the cytoskeleton influencing cell mem- 
brane  functions cannot be generalized for all cell 
processes.  In  Chang  liver  cells,  cytochalasin  B 
altered their shape  but  it had no inhibiting effect 
on the basal or fluoride or isoproterenol stimulated 
levels of adenyl cyclase (data not presented).  Fur- 
thermore,  cytochalasin  B,  although  a  potent  and 
competitive inhibitor of sugar transport,  was only 
weakly  inhibitory  toward  the  uptake  of  amino 
acids  and  thymidine  (12) 1 or  of inorganic  phos- 
phate  2, and had no effect on choline transport  (8). 
One explanation for the differential cytochalasin 
B inhibition of tyrosine aminotransferase induction 
by  the  hormones  versus  cyclic  AMP  takes  into 
account  the  role  of  microfilaments  and  micro- 
tubules in maintaining cell membrane architecture 
and  cell shape.  Puck  et al.  (13)  have shown  that 
treating  Chinese  hamster  ovary  cells  with  cyto- 
chalasin B  or Colcemid resulted  in violent exten- 
sions and retractions of the cell surface. The surface 
membrane effects were reversed by dibutyryl cyclic 
3~-5r-AMP; the plasma membrane became smooth 
and  tranquil.  The  cells  assumed  a  fusiform-like 
morphology with longer periods of culture  in the 
presence  of the  cyclic nucleotide.  The  shapes  of 
Reuber  H-35  cells  are  also  modified  by  cyclic 
nucleotides. Van Wijk et al.  (17)  have shown that 
the dibutyryl  and  two 8-thio derivatives of cyclic 
3t-5~-AMP inhibited  DNA synthesis and  the  rate 
of growth of the H-35 cells.  During this treatment, 
the cells became larger and developed long narrow 
processes;  these  effects  were  reversed  with  the 
removal of the  inhibitors.  The  shapes  of the  cul- 
tured  Reuber  hepatoma  cells are  also  altered  by 
cytochalasin B. The treated cells are round with a 
few narrow  processes  that remain attached  to the 
culture dish. 
It  is  conceivable  that  cytochalasin  B  prevents 
the induction  of tyrosine  aminotransferase  by the 
hormones  through  a  mechanism of microfilament 
depolymerization  with  concomitant  membrane 
perturbations  and  rearrangements.  Cyclic  AMP 
promotes  the  assembly  of microtubules  and  pos- 
sibly microfilaments.  As such,  exogenous levels of 
this  compound  could  become  antagonists  to  the 
effects of cytochalasin B on depolymerization and 
thereby  permit  the  nucleotide  to  function  in  its 
Warner, D., and J. F. Perdue. Unpublished observa- 
tions. 
other  roles,  including  the  induction  of  tyrosine 
aminotransferase. 
SUMMARY 
Cytochalasin B inhibited the induction of tyrosine 
aminotransferase  (E.C.  2.6.1.5)  by  insulin  and 
cortisol in  Reuber  H-35  hepatoma  cells.  The  in- 
duction  of this  enzyme  by dibutyryl  cyclic AMP 
was not inhibited  by cytochalasin B. 
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